SLC3A2 and cancer: In this study, we systematically analyzed the gene expression, epigenetic regulation, and genomic alterations of six key GLNM regulators (including SLC1A5, SLC7A5, SLC3A2, SLC7A11, GLS, and GLS2) across 33 different cancer types.